Chronic Hypoparathyroidism research hub
4 indexed studies · 2 currently recruiting
- active not recruitingPHASE3
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
This study is looking at a new medicine called eneboparatide for people with long-term hypoparathyroidism. It aims to find out if the medicine is safe and effective in helping to manage the condition.
United States · Canada · Denmark - active not recruitingPHASE2, PHASE3
A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
This study is testing a new medicine, linsitinib, for people with active, moderate to severe Thyroid Eye Disease (TED). Researchers want to see if it's safe and effective compared to a dummy pill over 24 weeks.
United States · Canada · Italy - recruitingNA
RT-CGM in Young Adults at Risk of DKA
This study looks at how a special device called real-time continuous glucose monitoring (RT-CGM) helps young adults, aged 18-25, manage their type 1 diabetes. We want to see if it improves blood sugar control and reduces hospital visits for high blood sugar.
United Kingdom - recruiting
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
The OSPREY Registry is looking at how a device called OncoSil™ works in people with locally advanced pancreatic cancer in normal hospital care. It watches how well the device performs and if there are any side effects when used with standard chemotherapy.
Spain · United Kingdom